Sub-analyses of three RDBPCT of SGLT2 inhibitor (canagliflozin [39, 40], luseogliflozin [41]) for the treatment of T2DM, serum transaminase activities in SGLT2 inhibitor-treated patients were significantly reduced compared to those in the placebo group
As always, it's best to follow usage directions and speak with a healthcare professional if you have individual dietary concerns
The study looked at individuals taking semaglutide for weight loss or diabetes management
Diabetic Retinopathy a condition that affects blood vessels in the retina, and especially dangerous if blood sugar improves too quickly
Ozempic, which uses the active ingredient semaglutide, was approved in the US for diabetes in 2017 and subsequently in the UK, and its counterpart for weight loss, Wegovy, was approved in the US in 2021